Both sleep duration and traits significantly influence cognitive health, making it crucial to identify optimal sleep patterns for preventing dementia.
Objective
To investigate the mutual effects of sleep duration and sleep traits on dementia risk.
Methods
This prospective study analyzed data from 359,505 participants in the UK Biobank, with baseline data collected between 2006–2010. Sleep patterns were assessed by constructing composite indicators through pairwise combinations of self-reported sleep duration and traits, including ease of getting up in the morning, chronotype, napping, daytime dozing, and use of sleep-related medications. The association between sleep patterns and dementia incidence was evaluated using Cox proportional hazards models during a mean follow-up period of 13.63 years.
Results
During the follow-up, 5123 participants developed dementia. In fully adjusted models, both short (≤6 h) and long (≥9 h) sleep durations, along with unfavorable sleep traits (hard or easy getting up, morning chronotype, habitual napping, dozing, sleep-related medications use), were significantly associated with increased dementia risk (p < 0.05). Notably, long sleep duration combined with evening chronotype (HR = 1.45, 95%CI: 1.15–1.83), habitual dozing (HR = 1.57, 95%CI: 1.18–2.09), or hypnotic use (HR = 2.71, 95%CI: 1.77–4.13) exhibited the highest risks compared to optimal sleep duration with corresponding alternative sleep traits. Similarly, short sleep duration combined with habitual napping carried the highest risk of dementia (HR = 1.54, 95%CI: 1.27–1.88).
Conclusions
Both sleep duration and traits are associated with dementia risk, particularly when abnormal duration interacts with unfavorable traits. These findings underscore the necessity of incorporating comprehensive sleep pattern assessments into dementia prevention strategies.
GaleSAAcarDDaffnerKR. Dementia. Am J Med2018; 131: 1161–1169.
2.
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet Public Health2022; 7: e105–e125.
3.
ChengST. Dementia caregiver burden: a research update and critical analysis. Curr Psychiatry Rep2017; 19: 64.
4.
DyerSMHarrisonSLLaverK, et al.An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia. Int Psychogeriatr2018; 30: 295–309.
5.
MoguilnerSGBerezukCBenderAC, et al.Sleep functional connectivity, hyperexcitability, and cognition in Alzheimer's disease. Alzheimers Dement2024; 20: 4234–4249.
6.
XuWTanCCZouJJ, et al.Sleep problems and risk of all-cause cognitive decline or dementia: an updated systematic review and meta-analysis. J Neurol Neurosurg Psychiatry2020; 91: 236–244.
7.
LowDVWuMNSpiraAP. Sleep duration and cognition in a nationally representative sample of U.S. older adults. Am J Geriatr Psychiatry2019; 27: 1386–1396.
8.
WinerJRDetersKDKennedyG, et al.Association of short and long sleep duration with amyloid-β burden and cognition in aging. JAMA Neurol2021; 78: 1187–1196.
9.
HuangYMXiaWGeYJ, et al.Sleep duration and risk of cardio-cerebrovascular disease: a dose-response meta-analysis of cohort studies comprising 3.8 million participants. Front Cardiovasc Med2022; 9: 907990.
10.
XiongYTvedtJÅkerstedtT, et al.Impact of sleep duration and sleep disturbances on the incidence of dementia and Alzheimer's disease: a 10-year follow-up study. Psychiatry Res2024; 333: 115760.
11.
WongATYReevesGKFloudS. Total sleep duration and daytime napping in relation to dementia detection risk: results from the million women study. Alzheimers Dement2023; 19: 4978–4986.
12.
LandryGJLiu-AmbroseT. Buying time: a rationale for examining the use of circadian rhythm and sleep interventions to delay progression of mild cognitive impairment to Alzheimer's disease. Front Aging Neurosci2014; 6: 325.
13.
SauersSCToedebuschCDRichardsonR, et al.Midpoint of sleep is associated with sleep quality in older adults with and without symptomatic Alzheimer's disease. Sleep Adv2024; 5: zpae023.
14.
HuangJZuberVMatthewsPM, et al.Sleep, major depressive disorder, and Alzheimer disease: a Mendelian randomization study. Neurology2020; 95: e1963–e1970.
15.
BarilAAPicardCLabontéA, et al.Longer sleep duration and neuroinflammation in at-risk elderly with a parental history of Alzheimer's disease. Sleep2024; 47: zsae081.
16.
FangSCHuangCJWuYL, et al.Effects of napping on cognitive function modulation in elderly adults with a morning chronotype: a nationwide survey. J Sleep Res2019; 28: e12724.
17.
TanXÅkerstedtTLagerrosYT, et al.Interactive association between insomnia symptoms and sleep duration for the risk of dementia-a prospective study in the Swedish National march cohort. Age Ageing2023; 52: afad163.
18.
LiPGaoLYuL, et al.Daytime napping and Alzheimer's dementia: a potential bidirectional relationship. Alzheimers Dement2023; 19: 158–168.
19.
NamsraiTAmbikairajahACherbuinN. Poorer sleep impairs brain health at midlife. Sci Rep2023; 13: 1874.
20.
HouJHSunSLTanCC, et al.Relationships of hypnotics with incident dementia and Alzheimer's disease: a longitudinal study and meta-analysis. J Prev Alzheimers Dis2024; 11: 117–129.
21.
BokenbergerKStrömPDahl AslanAK, et al.Shift work and cognitive aging: a longitudinal study. Scand J Work Environ Health2017; 43: 485–493.
22.
SudlowCGallacherJAllenN, et al.UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med2015; 12: e1001779.
23.
OstendorfBNPatelMABilanovicJ, et al.Common human genetic variants of APOE impact murine COVID-19 mortality. Nature2022; 611: 346–351.
24.
CassidySChauJYCattM, et al.Cross-sectional study of diet, physical activity, television viewing and sleep duration in 233,110 adults from the UK Biobank; the behavioural phenotype of cardiovascular disease and type 2 diabetes. BMJ Open2016; 6: e010038.
25.
MourrainPWangGX. Sleep: DNA repair function for better neuronal aging?Curr Biol2019; 29: R585–R588.
26.
XieLKangHXuQ, et al.Sleep drives metabolite clearance from the adult brain. Science2013; 342: 373–377.
27.
TempestaDSocciVDe GennaroL, et al.Sleep and emotional processing. Sleep Med Rev2018; 40: 183–195.
28.
CavaillèsCCarrièreIWagnerM, et al.Trajectories of sleep duration and timing before dementia: a 14-year follow-up study. Age Ageing2022; 51: afac186.
29.
OomsSOvereemSBesseK, et al.Effect of 1 night of total sleep deprivation on cerebrospinal fluid β-amyloid 42 in healthy middle-aged men: a randomized clinical trial. JAMA Neurol2014; 71: 971–977.
30.
BenedictCBlennowKZetterbergH, et al.Effects of acute sleep loss on diurnal plasma dynamics of CNS health biomarkers in young men. Neurology2020; 94: e1181–e1189.
31.
Shokri-KojoriEWangGJWiersCE, et al.β-Amyloid accumulation in the human brain after one night of sleep deprivation. Proc Natl Acad Sci U S A2018; 115: 4483–4488.
32.
SpiraAPGamaldoAAAnY, et al.Self-reported sleep and β-amyloid deposition in community-dwelling older adults. JAMA Neurol2013; 70: 1537–1543.
33.
YaffeKNasrallahIHoangTD, et al.Sleep duration and white matter quality in middle-aged adults. Sleep2016; 39: 1743–1747.
34.
Clocchiatti-TuozzoSRivierCARenedoD, et al.Suboptimal sleep duration is associated with poorer neuroimaging brain health profiles in middle-aged individuals without stroke or dementia. J Am Heart Assoc2024; 13: e031514.
35.
ReevesBCKarimyJKKundishoraAJ, et al.Glymphatic system impairment in Alzheimer's disease and idiopathic normal pressure hydrocephalus. Trends Mol Med2020; 26: 285–295.
36.
NagaiMHoshideSNishikawaM, et al.Sleep duration and insomnia in the elderly: associations with blood pressure variability and carotid artery remodeling. Am J Hypertens2013; 26: 981–989.
37.
HenryAKatsoulisMMasiS, et al.The relationship between sleep duration, cognition and dementia: a Mendelian randomization study. Int J Epidemiol2019; 48: 849–860.
38.
GuoY. Mendelian randomization study of self-reported long sleep duration, short sleep duration, and insomnia and cognitive function. PLoS One2025; 20: e0330782.
39.
WangQXuSLiuF, et al.Causal relationship between sleep traits and cognitive impairment: a Mendelian randomization study. J Evid Based Med2023; 16: 485–494.
40.
BasnerMRaoHGoelN, et al.Sleep deprivation and neurobehavioral dynamics. Curr Opin Neurobiol2013; 23: 854–863.
41.
LimASKowgierMYuL, et al.Sleep fragmentation and the risk of incident Alzheimer's disease and cognitive decline in older persons. Sleep2013; 36: 1027–1032.
42.
BellesiMPfister-GenskowMMaretS, et al.Effects of sleep and wake on oligodendrocytes and their precursors. J Neurosci2013; 33: 14288–14300.
43.
PatelSRZhuXStorfer-IsserA, et al.Sleep duration and biomarkers of inflammation. Sleep2009; 32: 200–204.
44.
RauchsGHarandCBertranF, et al.Sleep and episodic memory: a review of the literature in young healthy subjects and potential links between sleep changes and memory impairment observed during aging and Alzheimer's disease. Rev Neurol (Paris)2010; 166: 873–881.
45.
WittmannMDinichJMerrowM, et al.Social jetlag: misalignment of biological and social time. Chronobiol Int2006; 23: 497–509.
46.
MograssMAbi-JaoudeJFrimpongE, et al.The effects of napping on night-time sleep in healthy young adults. J Sleep Res2022; 31: e13578.
47.
GandhiKDMansukhaniMPSilberMH, et al.Excessive daytime sleepiness: a clinical review. Mayo Clin Proc2021; 96: 1288–1301.
HastingsMHGoedertM. Circadian clocks and neurodegenerative diseases: time to aggregate?Curr Opin Neurobiol2013; 23: 880–887.
50.
HoytKRObrietanK. Circadian clocks, cognition, and Alzheimer's disease: synaptic mechanisms, signaling effectors, and chronotherapeutics. Mol Neurodegener2022; 17: 35.
51.
FeiCJLiZYNingJ, et al.Exome sequencing identifies genes associated with sleep-related traits. Nat Hum Behav2024; 8: 576–589.
52.
ShinSSeokJWKimK, et al.Poor sleep quality is associated with decreased regional brain glucose metabolism in healthy middle-aged adults. Neuroimage2024; 298: 120814.
53.
IrwinMRVitielloMV. Implications of sleep disturbance and inflammation for Alzheimer's disease dementia. Lancet Neurol2019; 18: 296–306.
54.
GrandnerMABuxtonOMJacksonN, et al.Extreme sleep durations and increased C-reactive protein: effects of sex and ethnoracial group. Sleep2013; 36: 769–779e.
55.
DavisJMWeaverJAKohutML, et al.Immune system activation and fatigue during treadmill running: role of interferon. Med Sci Sports Exerc1998; 30: 863–868.
56.
LongJMHoltzmanDM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell2019; 179: 312–339.
57.
KalariaRN. The pathology and pathophysiology of vascular dementia. Neuropharmacology2018; 134: 226–239.
58.
ArvanitakisZShahRCBennettDA. Diagnosis and management of dementia: review. JAMA2019; 322: 1589–1599.
59.
MahalakshmiAMRayBTuladharS, et al.Sleep, brain vascular health and ageing. Geroscience2020; 42: 1257–1283.
60.
PlanteGE. Sleep and vascular disorders. Metabolism2006; 55: S45–S49.
61.
EvansMABuysseDJMarslandAL, et al.Meta-analysis of age and actigraphy-assessed sleep characteristics across the lifespan. Sleep2021; 44: zsab088.
62.
JacobsonLHHoyerD. Losing sleep with age. Science2022; 375: 816–817.
63.
ÅkerstedtTTrolle-LagerrosYWidmanL, et al.Sleep duration and mortality, influence of age, retirement, and occupational group. J Sleep Res2022; 31: e13512.
64.
LiJVitielloMVGooneratneNS. Sleep in normal aging. Sleep Med Clin2018; 13: 1–11.
65.
ScullinMKBliwiseDL. Sleep, cognition, and normal aging: integrating a half century of multidisciplinary research. Perspect Psychol Sci2015; 10: 97–137.
66.
MongJACusmanoDM. Sex differences in sleep: impact of biological sex and sex steroids. Philos Trans R Soc Lond B Biol Sci2016; 371: 20150110.
67.
HarringtonYAParisiJMDuanD, et al.Sex hormones, sleep, and memory: interrelationships across the adult female lifespan. Front Aging Neurosci2022; 14: 800278.
68.
RasmussenKLTybjaerg-HansenANordestgaardBG, et al.APOE And dementia - resequencing and genotyping in 105,597 individuals. Alzheimers Dement2020; 16: 1624–1637.
69.
BellouVBelbasisLTzoulakiI, et al.Systematic evaluation of the associations between environmental risk factors and dementia: an umbrella review of systematic reviews and meta-analyses. Alzheimers Dement2017; 13: 406–418.
70.
AlDawsariABushellTJAbutheraaN, et al.Use of sedative-hypnotic medications and risk of dementia: a systematic review and meta-analysis. Br J Clin Pharmacol2022; 88: 1567–1589.
71.
BloomFE. Neural mechanisms of benzodiazepine actions. Am J Psychiatry1977; 134: 669–672.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
